Li, G., Zhang, J., Xu, Z., & Li, Z. (2020). ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway. Cancer Manag Res.
Styl ChicagoLi, Guangliang, Jing Zhang, Zhenzhen Xu, a Zhongqi Li. "ERα36 As a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway." Cancer Manag Res 2020.
Citace podle MLALi, Guangliang, Jing Zhang, Zhenzhen Xu, a Zhongqi Li. "ERα36 As a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway." Cancer Manag Res 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..